Live News Categoriesequity

Ryvu Therapeutics S.A. (RVU.WA) News

Follow Ryvu Therapeutics S.A. (RVU.WA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol RVU.WA Asset equity Sector Markets 90 days 1 Last 15.8 Updated Sep 18, 2026, 01:17 PM UTC Open live news feed Open RVU.WA chart & news

L BRIEF — Ryvu Therapeutics Signs Grant Agreement For Panacea — Novo Project With The National Center For Research And Development Sept 18 (Reuters) — Ryvu Therapeutics SA: Signs Grant Agreement For Panacea-novo Project With The National Center For Research And Development Net Value Of Project At 133.2 Million Zlotys With Recommended Grant Value Of NEWS | Sep 18, 2026, 01:17 PM UTC